|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Procrit
|
|
gptkbp:activities
|
stimulates erythropoiesis
|
|
gptkbp:appointed_by
|
injection
|
|
gptkbp:approves
|
gptkb:1989
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Procrit
gptkb:Epogen
gptkb:Eprex
|
|
gptkbp:clinical_trial
|
Phase II
Phase III
Phase I
|
|
gptkbp:contraindication
|
pure red cell aplasia
uncontrolled hypertension
|
|
gptkbp:dosage_form
|
solution for injection
|
|
gptkbp:formulation
|
lyophilized powder
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Epogen
|
|
gptkbp:indication
|
chronic kidney disease
chemotherapy-induced anemia
HIV-related anemia
|
|
gptkbp:ingredients
|
gptkb:epoetin_alfa
|
|
gptkbp:invention
|
gptkb:Amgen_Inc.
|
|
gptkbp:is_used_for
|
treatment of anemia
|
|
gptkbp:manager
|
intravenous
subcutaneous
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
Epoetin alfa
|
|
gptkbp:produced_by
|
gptkb:Amgen
|
|
gptkbp:related_to
|
erythropoietin
|
|
gptkbp:shelf_life
|
24 months
|
|
gptkbp:side_effect
|
fatigue
headache
nausea
hypertension
injection site reactions
|
|
gptkbp:storage
|
refrigerated
|